Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GY.1.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HK.3.11NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JC.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.564NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.461NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.486NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.603NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.70NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.606NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.601NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.186NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.324NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
KC.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
KL.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.507NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.54NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.196NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.57NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.34NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.459NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.117NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.381NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.237NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.382NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.395NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.37NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.61NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.40NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.153NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.33NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.10NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.62NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.391NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.448NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Q.1 (Alpha)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.46 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.99 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JN.2.2.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JC.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
KE.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FY.8.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.30NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.56NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JD.1.1.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XDTNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HK.21NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JN.2.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used